July 17, 2020 / 7:12 AM / a month ago

REFILE-India's Cadila to end late-stage trials of potential COVID-19 vaccine in March

(Removes extraneous words from paragraph 1)

By Sumit Khanna

AHMEDABAD, India July 17 (Reuters) - India’s Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters.

Cadila’s vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus. (Writing by Zeba Siddiqui; Editing by Edmund Blair)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below